January 25, 2018 / 5:09 PM / a year ago

BRIEF-Adocia Announces Positive Topline Data From Study Of Biochaperone®

Jan 25 (Reuters) - Adocia Sa:

* ADOCIA ANNOUNCES POSITIVE TOPLINE DATA FROM A DOSE-PROPORTIONALITY STUDY OF BIOCHAPERONE® COMBO IN PEOPLE WITH TYPE 2 DIABETES

* ADOCIA SA - STUDY CONFIRMED PREVIOUS RESULTS THAT BIOCHAPERONE COMBO ACTS SIGNIFICANTLY FASTER AND LASTS SIGNIFICANTLY LONGER THAN HUMALOGMIX

* ADOCIA SA - ‍ALL TREATMENTS WERE WELL TOLERATED​

* ADOCIA SA - BOTH PRIMARY ENDPOINTS WERE MET IN STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below